Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · see citing works

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · see citing works

Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator

West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · see citing works

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439 · see citing works

Mitochondria take center stage in aging and neurodegeneration

Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20624 · Cited by 957 · see citing works

Mitochondrial damage induced by conditions of oxidative stress

Kowaltowski, A. J., & Vercesi, A. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00216-0 · Cited by 866 · see citing works

Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis

Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U. M., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808 · see citing works

Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury

Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782 · see citing works

Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

Kong, J., & Xu, Z. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03241.1998 · Cited by 723 · see citing works

Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis

Kruman, I. I., Bruce‐Keller, A. J., Bredesen, D. E., Waeg, G., & Mattson, M. P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05089.1997 · Cited by 719 · see citing works

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis

Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682 · see citing works

Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice

Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., Martushova, K., Kiaei, M., Beal, M. F., & Manfredi, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203065200 · Cited by 616 · see citing works

Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

Beal, M. F., Ferrante, R. J., Browne, S. E., Matthews, R. T., Kowall, N. W., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410420416 · Cited by 599 · see citing works

Coenzyme Q ₁₀ administration increases brain mitochondrial concentrations and exerts neuroprotective effects

Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8892 · Cited by 557 · see citing works

Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation

Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · see citing works

Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria

Liu, J., Lillo, C., Jonsson, P. A., Velde, C. V., Ward, C. M., Miller, T. M., Subramaniam, J. R., Rothstein, J. D., Marklund, S. L., Andersen, P. M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.016 · Cited by 506 · see citing works

Amyotrophic Lateral Sclerosis-Associated SOD1 Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria

Pasinelli, P., Belford, M. E., Lennon, N. J., Bacskai, B. J., Hyman, B. T., Trotti, D., & Brown, R. H. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.021 · Cited by 506 · see citing works

Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis

Pasinelli, P., Houseweart, M. K., Brown, R. H., & Cleveland, D. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240305897 · Cited by 344 · see citing works

Increased lipid peroxidation in sera of ALS patients

Simpson, E. P., Henry, Y. K., Henkel-Tigges, J., Smith, R. G., & Appel, S. H. (2004) · Neurology · doi:10.1212/wnl.62.10.1758 · Cited by 328 · see citing works

Mitochondrial Implication in Accidental and Programmed Cell Death: Apoptosis and Necrosis

Zamzami, N., Hirsch, T., Dallaporta, B., PETIT, P. X., & Kroemer, G. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022694131572 · Cited by 326 · see citing works

Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant

Bruijn, L. I., Beal, M. F., Bêcher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., & Cleveland, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7606 · Cited by 290 · see citing works

Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis

Menzies, F. M. (2002) · Brain · doi:10.1093/brain/awf167 · Cited by 279 · see citing works

ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes

Higgins, C. M. J., Jung, C., & Xu, Z. (2003) · BMC Neuroscience · doi:10.1186/1471-2202-4-16 · Cited by 262 · see citing works

Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines

Zhao, K., Luo, G., Giannelli, S., & Szeto, H. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.022 · Cited by 251 · see citing works

Mutant Superoxide Dismutase 1 Forms Aggregates in the Brain Mitochondrial Matrix of Amyotrophic Lateral Sclerosis Mice

Vijayvergiya, C., Beal, M. F., Buck, J., & Manfredi, G. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4385-04.2005 · Cited by 251 · see citing works

Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation

Ferrante, R. J., Shinobu, L. A., Schulz, J. B., Matthews, R. T., Thomas, C. E., Kowall, N. W., Gurney, M. E., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420309 · Cited by 251 · see citing works

Neural mitochondrial Ca 2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn‐superoxide dismutase mutant mice

Damiano, M. G., Starkov, A. A., Petri, S., Kipiani, K., Kiaei, M., Mattiazzi, M., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03619.x · Cited by 247 · see citing works

Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH‐SY5Y cells

Carrı̀, M. T., Ferri, A., Battistoni, A., Famhy, L., Gabbianelli, R., Poccia, F., & Rotilio, G. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01051-x · Cited by 221 · see citing works

Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase

Pasinelli, P., Borchelt, D., Houseweart, M. K., Cleveland, D. W., & Brown, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15763 · Cited by 221 · see citing works

Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

Klivènyi, P., Kiaei, M., Gardian, G., Calingasan, N. Y., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02160.x · Cited by 201 · see citing works

The Lipid Peroxidation Product 4‐Hydroxynonenal Inhibits Neurite Outgrowth, Disrupts Neuronal Microtubules, and Modifies Cellular Tubulin

Neely, M. D., Sidell, K. R., Graham, D. G., & Montine, T. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722323.x · Cited by 186 · see citing works

Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis

Casoni, F., Basso, M., Massignan, T., Gianazza, E., Cheroni, C., Salmona, M., Bendotti, C., & Bonetto, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413111200 · Cited by 180 · see citing works

Synthesis and in vitro opioid activity profiles of DALDA analogues

Schiller, P. W., Nguyen, T. M. ‐., Berezowska, I., Dupuis, S., Weltrowska, G., Chung, N. N., & Lemieux, C. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01171-5 · Cited by 162 · see citing works

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161 · see citing works

Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis

Marzia Perluigi, A., Poon, H. F., Hensley, K., Pierce, W. M. J., Klein, J. B., Calabrese, V., Marco, C. M. D., & Butterfield, D. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.021 · Cited by 151 · see citing works

Transcellular Transport of a Highly Polar 3+ Net Charge Opioid Tetrapeptide

Zhao, K., Luo, G., Zhao, G., Schiller, P. W., & Szeto, H. H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040147 · Cited by 150 · see citing works

Manganese porphyrin given at symptom onset markedly extends survival of ALS mice

Crow, J. P., Calingasan, N. Y., Chen, J., Hill, J. L., & Beal, M. F. (2005) · Annals of Neurology · doi:10.1002/ana.20552 · Cited by 136 · see citing works

Mitochondrial dysfunction and amyotrophic lateral sclerosis

Hervías, I., Beal, M. F., & Manfredi, G. (2005) · Muscle & Nerve · doi:10.1002/mus.20489 · Cited by 122 · see citing works

Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis

Aguirre, N., Beal, M. F., Matson, W. R., & Bogdanov, M. B. (2005) · Free Radical Research · doi:10.1080/10715760400027979 · Cited by 90 · see citing works

Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis

Wu, A. S., Kiaei, M., Aguirre, N., Crow, J. P., Calingasan, N. Y., Browne, S. E., & Beal, M. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01639.x · Cited by 88 · see citing works

Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria

Galindo, M. F., Jordán, J., Gonzalez-Garcia, C., & Ceña, V. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705309 · Cited by 73 · see citing works

Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction

Neely, M. D., Boutté, A. M., Milatović, D., & Montine, T. J. (2005) · Brain Research · doi:10.1016/j.brainres.2004.12.027 · Cited by 65 · see citing works

RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells

Maxwell, M. M., Pasinelli, P., Kazantsev, A. G., & Brown, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308726100 · Cited by 59 · see citing works

Induction of motor neuron apoptosis by free 3‐nitro‐ l ‐tyrosine

Peluffo, H., Shacka, J. J., Ricart, K. C., Bisig, C. G., Palma, L. M., Pritsch, O., Kamaid, A., Eiserich, J. P., Crow, J. P., Barbeito, L., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2004.02363.x · Cited by 56 · see citing works

A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats

Song, W., Shin, J., Lee, J., Kim, H. J., Oh, D.-J., Edelberg, J. M., Wong, S. C., Szeto, H. H., & Hong, M. K. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200509000-00011 · Cited by 31 · see citing works

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans

Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · see citing works

Mitochondrial Dysfunction in Neurodegenerative Diseases

Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806 · see citing works

Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities

Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742 · see citing works

First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics

Szeto, H. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12461 · Cited by 550 · see citing works

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 540 · see citing works

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

Turner, B. J., & Talbot, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 495 · see citing works

Mitochondrial oxidative stress in aging and healthspan

Dai, D., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., & Rabinovitch, P. S. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-6 · Cited by 481 · see citing works

Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases

Giorgi, C., Marchi, S., Simões, I. C. M., Ren, Z., Morciano, G., Perrone, M., Patalas‐Krawczyk, P., Borchard, S., Jędrak, P., Pierzynowska, K., et al. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 467 · see citing works

Mitochondria and Cardiovascular Aging

Dai, D., Rabinovitch, P. S., & Ungvari, Z. I. (2012) · Circulation Research · doi:10.1161/circresaha.111.246140 · Cited by 435 · see citing works

Mitochondrial Diseases of the Brain

Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works

Amyotrophic Lateral Sclerosis: A Focus on Disease Progression

Calvo, A. C., Manzano, R., de Mendonça, D. M. F., Muñoz, M. J., Zaragoza, P., & Osta, R. (2014) · BioMed Research International · doi:10.1155/2014/925101 · Cited by 404 · see citing works

Neuroprotective strategies involving ROS in Alzheimer disease

Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402 · see citing works

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics

Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · see citing works

Mitochondria-targeted peptide antioxidants: Novel neuroprotective agents

Szeto, H. H. (2006) · The AAPS Journal · doi:10.1208/aapsj080362 · Cited by 332 · see citing works

Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease

Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4179 · Cited by 334 · see citing works

Mitochondria as a Therapeutic Target in Heart Failure

Bayeva, M., Gheorghiade, M., & Ardehali, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 336 · see citing works

Oxidative stress in spinal cord injury and antioxidant-based intervention

Jia, Z., Zhu, H., Li, J., Wang, X., Misra, H., & Li, Y. (2011) · Spinal Cord · doi:10.1038/sc.2011.111 · Cited by 330 · see citing works

Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications

Apostolova, N., & Víctor, V. M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5952 · Cited by 303 · see citing works

Mitochondrial Approaches for Neuroprotection

Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works

Mitochondria: A therapeutic target in neurodegeneration

Moreira, P. I., Zhu, X., Wang, X., Lee, H., Nunomura, A., Petersen, R. B., Perry, G. L., & Smith, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 286 · see citing works

Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration

Patten, D. A., Germain, M., Kelly, M., & Slack, R. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100498 · Cited by 280 · see citing works

Metformin: Is it a drug for all reasons and diseases?

Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R. S., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 282 · see citing works

Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury

Szeto, H. H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 269 · see citing works

Effects of natural antioxidants in neurodegenerative disease

Albarracín, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I. J., González, J., Gonzalo, L., Capani, F., Morales, L., & Barreto, G. E. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000028 · Cited by 273 · see citing works

Mitochondrial dysfunction in ALS

Cozzolino, M., & Carrı̀, M. T. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.003 · Cited by 239 · see citing works

Mitochondrial Medicine for Aging and Neurodegenerative Diseases

Reddy, P. H. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8044-z · Cited by 230 · see citing works

Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention

Cunha‐Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P. J., & Silva, F. S. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5021694 · Cited by 214 · see citing works

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice

Zhao, W., Xu, Z., Cao, J., Fu, Q., Wu, Y., Zhang, X., Yue, L., Zhang, X., Yang, Y., Li, Y., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1627-9 · Cited by 207 · see citing works

Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity

Szeto, H. H., & Birk, A. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.174 · Cited by 191 · see citing works

Mitochondrial Dysfunction in Aging and Alzheimer's Disease: Strategies to Protect Neurons

Reddy, P. H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1754 · Cited by 187 · see citing works

Mitochondria as a target in treatment

Frantz, M., & Wipf, P. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20554 · Cited by 177 · see citing works

A Novel Cell-permeable Antioxidant Peptide, SS31, Attenuates Ischemic Brain Injury by Down-regulating CD36

Cho, S., Szeto, H. H., Kim, E., Kim, H., Tolhurst, A. T., & Pinto, J. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609388200 · Cited by 170 · see citing works

Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development

Szeto, H. H., & Schiller, P. W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0476-8 · Cited by 170 · see citing works

Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity

Yang, L., Zhao, K., Calingasan, N. Y., Luo, G., Szeto, H. H., & Beal, M. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2445 · Cited by 169 · see citing works

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse

Morton, H., Kshirsagar, S., Orlov, E., Bunquin, L. E., Sawant, N. A., Boleng, L., George, M., Basu, T., Ramasubramanian, B., Pradeepkiran, J. A., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.013 · Cited by 171 · see citing works

Glutathione Binding to the Bcl-2 Homology-3 Domain Groove

Zimmermann, A. K., Loucks, F. A., Schroeder, E. K., Bouchard, R. J., Tyler, K. L., & Linseman, D. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702853200 · Cited by 163 · see citing works

Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications

Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156 · see citing works

Alzheimer's Disease: A Lesson from Mitochondrial Dysfunction

Moreira, P. I., Santos, M. S., & Oliveira, C. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1703 · Cited by 150 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics

Reddy, P. H. (2011) · Pharmaceuticals · doi:10.3390/ph4030429 · Cited by 143 · see citing works

Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease

Yin, X., Mańczak, M., & Reddy, P. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw045 · Cited by 142 · see citing works

Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease

Reddy, P. H., Mańczak, M., & Kandimalla, R. J. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx052 · Cited by 134 · see citing works

Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing

Gruber, J., Fong, S., Chen, C.-B., Yoong, S. L., Pastorin, G., Schaffer, S., Cheah, I. K.-M., & Halliwell, B. B. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.005 · Cited by 138 · see citing works

Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy

Sakellariou, G. K., Pearson, T., Lightfoot, A. P., Nye, G. A., Wells, N., Giakoumaki, I. I., Vasilaki, A., Griffiths, R. D., Jackson, M. J., & McArdle, A. (2016) · Scientific Reports · doi:10.1038/srep33944 · Cited by 133 · see citing works

A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome

Dare, A. J., Phillips, A. R. J., Hickey, A. J., Mittal, A., Loveday, B. P. T., Thompson, N. M., & Windsor, J. A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.019 · Cited by 138 · see citing works

Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix

Brand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123 · see citing works

Mitochondria: a new therapeutic target in chronic kidney disease

Granata, S., Gassa, A. D., Tomei, P., Lupo, A., & Zaza, G. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0044-z · Cited by 122 · see citing works

Mechanisms of Disease: DNA repair defects and neurological disease

Subba Rao, K. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0448 · Cited by 121 · see citing works

Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis

Pfohl, S. R., Halicek, M. T., & Mitchell, C. S. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140068 · Cited by 114 · see citing works

Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

Martinelli, C., Pucci, C., Battaglini, M., Marino, A., & Ciofani, G. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901589 · Cited by 111 · see citing works

Hemigramicidin–TEMPO conjugates: Novel mitochondria-targeted anti-oxidants

Fink, M. P., Macias, C. A., Xiao, J., Tyurina, Y. Y., Jiang, J., Belikova, N. A., Delude, R. L., Greenberger, J. S., Kagan, V. E., & Wipf, P. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.019 · Cited by 107 · see citing works

The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease

Camilleri, A., & Vassallo, N. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12264 · Cited by 104 · see citing works

Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy

Wu, J., Zhang, M., Hao, S., Jia, M., Ji, M., Qiu, L., Sun, X., Yang, J., & Li, K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8918-z · Cited by 104 · see citing works

Mitochondrial protein tyrosine nitration

Castro, L., Demicheli, V., Tórtora, V., & Radí, R. (2010) · Free Radical Research · doi:10.3109/10715762.2010.516254 · Cited by 100 · see citing works

Development of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases

Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100 · see citing works

Heart Failure and Mitochondrial Dysfunction

Knowlton, A. A., Chen, L., & Malik, Z. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000432861.55968.a6 · Cited by 97 · see citing works

Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease

Reddy, P. H., Mańczak, M., Yin, X., & Reddy, A. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170988 · Cited by 96 · see citing works

Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease

Calvo-Rodríguez, M., Kharitonova, E. K., Snyder, A. C., Hou, S. S., Sanchez-Mico, M. V., Das, S., Fan, Z., Shirani, H., Nilsson, K. P. R., Serrano‐Pozo, A., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00702-2 · Cited by 97 · see citing works

Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function

Thomas, D. A., Stauffer, C., Zhao, K., Yang, H., Sharma, V. K., Szeto, H. H., & Suthanthiran, M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080825 · Cited by 84 · see citing works

Mitochondrial medicine for neurodegenerative diseases

Du, H., & Yan, S. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.004 · Cited by 81 · see citing works

SS‐31 Provides Neuroprotection by Reversing Mitochondrial Dysfunction after Traumatic Brain Injury

Zhu, Y., Wang, H., Fang, J., Dai, W., Zhou, J., Wang, X., & Zhou, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4783602 · Cited by 79 · see citing works

Mitochondrial dysfunction in central nervous system white matter disorders

Morató, L., Bertini, E., Verrigni, D., Ardissone, A., Ruíz, M., Ferrer, I., Uziel, G., & Pujol, A. (2014) · Glia · doi:10.1002/glia.22670 · Cited by 75 · see citing works

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

Calkins, M. J., Mańczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 71 · see citing works

A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction

Mizuguchi, Y., Chen, J., Seshan, S. V., Poppas, D. P., Szeto, H. H., & Felsen, D. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00395.2007 · Cited by 72 · see citing works

Mitochondrially-targeted treatment strategies

Bozi, L. H. M., Campos, J. C., Zambelli, V. O., Ferreira, N. D., & Ferreira, J. C. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100836 · Cited by 65 · see citing works

Targeting mitochondrial bioenergetics as a promising therapeutic strategy in metabolic and neurodegenerative diseases

Bhatti, G. K., Gupta, A., Pahwa, P., Khullar, N., Singh, S., Navik, U., Kumar, S., Mastana, S. S., Reddy, A. P., Reddy, P. H., et al. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.002 · Cited by 65 · see citing works

Mitochondrial therapies for Parkinson's disease

Thomas, B., & Beal, M. F. (2010) · Movement Disorders · doi:10.1002/mds.22781 · Cited by 61 · see citing works

Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage

Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.006 · Cited by 62 · see citing works

Catalytic Antioxidants and Neurodegeneration

Golden, T. R., & Patel, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2256 · Cited by 61 · see citing works

BDNF pathway is involved in the protective effects of SS-31 on isoflurane-induced cognitive deficits in aging mice

Wu, J., Zhang, M., Li, H., Sun, X., Hao, S., Ji, M., Yang, J., & Li, K. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.02.036 · Cited by 58 · see citing works

Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies

Toyama, S., Shimoyama, N., Ishida, Y., Koyasu, T., Szeto, H. H., & Shimoyama, M. (2013) · Anesthesiology · doi:10.1097/01.anes.0000435634.34709.65 · Cited by 57 · see citing works

A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy

Bond, L., Bernhardt, K. D., Madria, P., Sorrentino, K., Scelsi, H. F., & Mitchell, C. S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00010 · Cited by 57 · see citing works

A Mitochondrion-Targeted Antioxidant Ameliorates Isoflurane-Induced Cognitive Deficits in Aging Mice

Wu, J., Li, H., Sun, X., Zhang, H., Hao, S., Ji, M., Yang, J., & Li, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138256 · Cited by 54 · see citing works

Oxidative Stress Treatment for Clinical Trials in Neurodegenerative Diseases

Ienco, E. C., LoGerfo, A., Carlesi, C., Orsucci, D., Ricci, G., Mancuso, M., & Siciliano, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110164 · Cited by 54 · see citing works

Mitochondrial oxidative stress and mammalian healthspan

Wanagat, J., Dai, D., & Rabinovitch, P. S. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.06.002 · Cited by 52 · see citing works

The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained

Joshi, A. U., Kornfeld, O. S., & Mochly‐Rosen, D. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.04.010 · Cited by 51 · see citing works

Protective effects of mitochondrion-targeted peptide SS-31 against hind limb ischemia-reperfusion injury

Cai, J., Jiang, Y. Y., Zhang, M., Zhao, H., Li, H., Li, K., Zhang, X., & Tong, Q. Z. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0617-1 · Cited by 48 · see citing works

Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration

Edens, B. M., Miller, N., & Ma, Y. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00044 · Cited by 51 · see citing works

Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases

Serviddio, G., Romano, A. D., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 45 · see citing works

Do Mitochondriotropic Antioxidants Prevent Chlorinative Stress-Induced Mitochondrial and Cellular Injury?

Whiteman, M., Spencer, J. P. E., Szeto, H. H., & Armstrong, J. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1879 · Cited by 44 · see citing works

Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes

Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44 · see citing works

Mitochondria and neuroprotection in stroke: Cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics

MacDougall, G., Anderton, R. S., Mastaglia, F. L., Knuckey, N. W., & Meloni, B. P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.010 · Cited by 41 · see citing works

Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice

Bhatti, J. S., Thamarai, K., Kandimalla, R., Manczak, M., Yin, X., Kumar, S., Vijayan, M., & Reddy, P. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02142-7 · Cited by 41 · see citing works

Prospects for neuroprotective therapies in prodromal Huntington's disease

Chandra, A., Johri, A., & Beal, M. F. (2014) · Movement Disorders · doi:10.1002/mds.25835 · Cited by 41 · see citing works

Novel Mitochondria-Targeted Antioxidant Peptide Ameliorates Burn-Induced Apoptosis and Endoplasmic Reticulum Stress in the Skeletal Muscle of Mice

Lee, H.-Y., Kaneki, M., Andreas, J., Tompkins, R. G., & Martyn, J. A. J. (2011) · Shock · doi:10.1097/shk.0b013e3182366872 · Cited by 41 · see citing works

Whether short peptides are good candidates for future neuroprotective therapeutics?

Perlikowska, R. (2021) · Peptides · doi:10.1016/j.peptides.2021.170528 · Cited by 42 · see citing works

Mitochondria-Directed Therapeutics

Armstrong, J. S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1929 · Cited by 40 · see citing works

Mitophagy in Alzheimer's disease and other metabolic disorders: A focus on mitochondrial-targeted therapeutics

Skawratananond, S., Xiong, D. X., Zhang, C., Tonk, S. S., Pinili, A., Delacruz, B., Pham, P., Smith, S. C., Navab, R., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102732 · Cited by 39 · see citing works

Mitochondrial‐Targeting Antioxidant SS‐31 Suppresses Airway Inflammation and Oxidative Stress Induced by Cigarette Smoke

Yang, D., Zuo, Q., Wang, T., Xu, D., Liu, L., Gao, L., Wan, C., Chen, L., Wen, F., & Shen, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6644238 · Cited by 36 · see citing works

Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism

Yo, K., Yu, Y., Zhao, G., Bonab, A. A., Aikawa, N., Tompkins, R. G., & Fischman, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00098.2012 · Cited by 35 · see citing works

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34 · see citing works

Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease

Mangrulkar, S. V., Wankhede, N. L., Kale, M. B., Upaganlawar, A. B., Taksande, B. G., Umekar, M. J., Anwer, M. K., Dailah, H. G., Mohan, S., & Behl, T. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00647-2 · Cited by 35 · see citing works

Metal attenuating therapies in neurodegenerative disease

Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 31 · see citing works

Strategic approaches to developing drug treatments for ALS

Vincent, A. M., Sakowski, S. A., Schuyler, A. D., & Feldman, E. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.011 · Cited by 32 · see citing works

An Update on Antioxidative Stress Therapy Research for Early Brain Injury After Subarachnoid Hemorrhage

Lin, F., Li, R., Tu, W., Chen, Y., Wang, K., Chen, X., & Zhao, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.772036 · Cited by 31 · see citing works

Strategies to protect against age-related mitochondrial decay: Do natural products and their derivatives help?

Visioli, F., Ingram, A., Beckman, J. S., Magnusson, K. R., & Hagen, T. M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.12.008 · Cited by 31 · see citing works

Relationships between Exercise, Mitochondrial Biogenesis and Type 2 Diabetes

Joseph, A.-M., & Hood, D. A. (2014) · Medicine and sport science/Medicine and sport · doi:10.1159/000357335 · Cited by 32 · see citing works

Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, Tallyho/JngJ mice

Bhatti, J. S., Tamarai, K., Kandimalla, R., Manczak, M., Yin, X., Ramasubramanian, B., Sawant, N., Pradeepkiran, J. A., Vijayan, M., Kumar, S., et al. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.02.007 · Cited by 30 · see citing works

A synthetic cell permeable antioxidant protects neurons against acute oxidative stress

Drummond, N. J., Davies, N. O., Lovett, J. E., Miller, M. R., Cook, G., Becker, T., Becker, C. G., McPhail, D. B., & Kunath, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-12072-5 · Cited by 30 · see citing works

SS31 attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage possibly by the mitochondrial pathway

Shen, R., Zhou, J., Li, G., Chen, W., Zhong, W., & Chen, Z. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134654 · Cited by 29 · see citing works

Mitochondria as Potential Targets in Antidiabetic Therapy

Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 27 · see citing works

Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis

Zhang, Y., Li, H., Chen, Y., Fan, D.-F., Guo, D.-Z., Hu, H., Meng, X.-E., & Pan, S. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1750-7 · Cited by 17 · see citing works

Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1‐mediated motor neuron cell death and increase amyotrophic lateral sclerosis‐like transgenic mouse survival

Liu, R., Li, B., Flanagan, S. W., Oberley, L. W., Gozal, D., & Qiu, M. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00720.x · Cited by 110 · see citing works

Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis

Liu, K. X., Edwards, B., Lee, S., Finelli, M. J., Davies, B., Davies, K. E., & Oliver, P. L. (2015) · Brain · doi:10.1093/brain/awv039 · Cited by 85 · see citing works

Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis

Miquel, E., Cassina, A., Palma, L. M., Souza, J. M., Bolatto, C., Rodríguez-Bottero, S., Logan, A., Smith, R. A. J., Murphy, M. P., Barbeito, L., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.019 · Cited by 139 · see citing works

Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention

Cunha‐Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P. J., & Silva, F. S. G. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5021694 · Cited by 214 · see citing works